AZTR news today — last 24 hours, 7 days, 30 days

AZITRA INC (AZTR) — News & AI sentiment

AZITRA INC (AZTR) news roundup. 2 stories in the last 24 hours, 7 in the past week, 16 over 30 days. Average 24-hour sentiment is 31/100 — bearish-leaning (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

avg sentiment 31/100

7d stories

avg sentiment 47.6/100

30d stories

avg sentiment 49.1/100

Insider net (90d)

0 buys · 0 sells

Congress (90d)

0 buys · 0 sells

AZTR news in the last 24 hours, 7 days, 30 days and 90 days

How much AZTR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	AZTR stories	Avg AI sentiment	Read
Last 24 hours	2	31/100	AZTR headlines →
Last 7 days	7	47.6/100	AZTR headlines →
Last 30 days	16	49.1/100	AZTR headlines →
Last 90 days	28	51.7/100	AZTR headlines →

Latest stories on AZTR

Azitra GAAP EPS of -$0.29 misses by $0.04

Business Insider34 · bearishearnings

6h ago

Azitra price target lowered to $4 from $10 at Maxim

The Fly28 · bearishanalyst

9h ago

Azitra, Inc. Announces Q3 2026 Results and Provides Business Updates

StockTitan55 · neutralearnings

1d ago

Azitra, Inc. (AZTR) files 8-K: Items 2.02, 9.01

SEC 8-K50 · neutralgeneral

1d ago

Azitra Reports ATR-COSF Wrinkle Reduction in Skin Model

TipRanks58 · neutralproduct/pr

3d ago

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

3d ago

Azitra, Inc. to Present Research at BIO-Europe® Showing ATR-COSF Reduced Fine Lines and Improved Elasticity in Ex Vivo Human Skin Models

StockTitan58 · neutralproduct/pr

3d ago

Azitra Amends ATR04-484 Trial, Expands Rash Eligibility

TipRanks58 · neutralproduct/pr

Oct 29

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Oct 29

Azitra, Inc. Expands Eligibility for ATR-04 Phase 1/2 Clinical Trial to Include Patients with Rashes due to KRAS and MEK Inhibitors

PR Newswire61 · neutralproduct/pr

Oct 29

Azitra’s ATR-COSF shows skin revitalizing effectivity in ex vivo study

The Fly58 · neutralproduct/pr

Oct 26

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Oct 26

Azitra, Inc. Announces Revitalizing Results from Ex Vivo Study of ATR-COSF Demonstrating Ability to Reduce Fine Lines and Improve Elasticity in Human Skin

StockTitan63 · neutralproduct/pr

Oct 26

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Oct 22

Azitra announces 1-for-10 reverse stock split

The Fly31 · bearishgeneral

Oct 16

Azitra, Inc. Announces Reverse Stock Split

PR Newswire31 · bearishgeneral

Oct 16

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Oct 1

Azitra, Inc. Advances ATR-04 Phase 1/2 Clinical Trial to Cohort 2 Following Safety Review Committee Clearance

PR Newswire67 · bullishproduct/pr

Oct 1

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Sep 28

Azitra to Present Corporate Update at Investment Conference

TipRanks55 · neutralgeneral

Sep 8

Azitra, Inc. (AZTR) files 8-K

SEC 8-K50 · neutralgeneral

Sep 8

Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference

PR Newswire55 · neutralgeneral

Sep 8

Azitra regains NYSE American listing compliance

Seeking Alpha59 · neutralgeneral

Aug 21

Azitra Regains NYSE American Listing Compliance Status

TipRanks55 · neutralgeneral

Aug 21

Azitra regains NYSE American compliance

The Fly59 · neutralgeneral

Aug 21